Lymphopenia during treatment with dimethyl fumarate in patients with multiple sclerosis: Prevalence, predicting factors and clinical outcomes

Alessandro Dinoto,Arianna Sartori,Marta Cheli,Fulvio Pasquin,Sara Baldini,Alessio Bratina,Antonio Bosco,Paolo Manganotti

Multiple Sclerosis and Related Disorders（2022）

引用 3|浏览1

暂无评分

摘要

•Lymphopenia is a common side effect of treatment with dimethyl fumarate.•Basal absolute lymphocyte count best predicts the development of lymphopenia.•Lymphopenia is not associated with NEDA-3 status.

查看译文

关键词

Multiple sclerosis,Dimethyl fumarate,Lymphopenia,Disease modifying drugs

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要